Document is current
Any future updates will be listed below
-
Authors
Valsamidis, Thomas Nikolas
Tøttrup, Anders
Ljungmann, Ken
Avlund, Tue Højslev
Harsløf, Sanne
Buchard, Charlotte
Iversen, Lene Hjerrild
-
Funding
Funding for this research was provided by:
Kræftens Bekæmpelse (R320-A18522)
Kræftens Bekæmpelse (R302-A17607)
Aarhus Universitet
- License Information
-
More Information
Article History
Accepted: 28 March 2025
First Online: 5 April 2025
Declarations
:
: The study was approved by The Central Denmark Region Committees on Health Research Ethics.
: Written informed consent was obtained from included patients and the Helsinki declaration was followed in all aspects.
: Professor Lene Hjerrild Iversen, Aarhus University Hospital, Denmark, received funding from the Danish Cancer Society (grant no. R302-A17607) to cover the costs of the Obsidian® ASG preparation units and salary of a study nurse. A grant was also provided by the Danish Cancer Society, supporting a research year by Thomas Nikolas Valsamidis focused on the above research, by providing the salary for the researcher (grant no. R320-A18522). No other funds, grants, or other support was received. Thomas Nikolas Valsamidis, Anders Tøttrup, Ken Ljungmann, Tue Højslev Avlund, Sanne Harsløf, Charlotte Buchard, and Lene Hjerrild Iversen have no other conflicts of interest to disclose.
